Abstract
Modern deep learning models for medical image segmentation often struggle with "hard samples"—outliers characterized by rare pathologies, irregular boundaries, or imaging artifacts. This paper introduces L2S (Learning to Segment hard samples), a novel framework designed to explicitly identify and process these challenging cases. L2S utilizes a dynamic identification mechanism and a specialized segmentation pipeline that leverages a diffusion process as an implicit second-order regularizer. Evaluated across six diverse medical datasets, L2S demonstrates substantial performance improvements, particularly on hard samples, outperforming existing state-of-the-art methods.
Introduction
In the clinical application of medical image segmentation, the "long-tail" distribution of data presents a significant hurdle. While standard models like U-Net perform well on average cases, they frequently fail on rare or complex instances. These "hard samples" include images with structural changes, pathological variations, or significant noise and artifacts. Traditional approaches typically rely on end-to-end training or coarse-to-fine refinement. However, end-to-end models often lack the robustness to handle outliers, and coarse-to-fine strategies are highly dependent on the quality of the initial coarse prediction.
The L2S Framework
The proposed L2S framework shifts the paradigm by treating sample difficulty as a dynamic feature. The architecture consists of two primary stages: identifying hard samples and applying a specialized segmentation strategy.
1. Learning to Identify Hard Samples
Rather than using a static metric for difficulty, L2S employs a backbone model and a classifier to categorize samples as "normal" or "hard" (unqualified). To ensure the model remains challenged throughout training, the authors use Bayesian Optimization with a Gaussian Process to adaptively update the hardness threshold. This creates an evolving curriculum where the definition of a "hard sample" shifts as the model's general performance improves.
2. Learning to Segment Hard Samples
Samples identified as hard are routed through a specialized pipeline designed for robustness:
- Diffusion-based Feature Augmentation: The framework uses a diffusion process to corrupt and reconstruct feature representations. This acts as an implicit second-order (Hessian) regularizer, encouraging the model to find flatter minima in the loss landscape, which enhances generalization on outlier data.
- Mix-Former: This module integrates noise embeddings with image features using attention mechanisms in the Fourier (frequency) domain. This approach is particularly effective at separating structural information from the noise and artifacts common in hard samples.
- Multiscale Transformer Decoder: Utilizing learnable queries, this component extracts precise anatomical details from the augmented features, allowing for high-fidelity segmentation of complex structures.
Experimental Results
The L2S framework was rigorously tested on six public medical segmentation datasets, including COSMOS2022 (carotid artery), ISIC2018 (skin lesions), and BTCV (abdominal organs). L2S consistently established new state-of-the-art (SOTA) benchmarks. Notably, on the ISIC dataset, L2S improved the Dice score for hard samples by 8.97% compared to previous methods. On the COSMOS2022 dataset, it achieved a 10.88% improvement in the overall Dice score.
Qualitative analysis highlights L2S's ability to maintain boundary integrity and identify narrow structures, such as vessel stenoses, where other models often produce fragmented or overly smoothed results. On the BTCV dataset, L2S reached an average Dice score of 88.2%, setting a new high bar for abdominal organ segmentation.
Discussion and Conclusion
The L2S framework addresses a critical gap in medical AI by focusing on the robustness of segmentation in the face of data variability. The integration of diffusion as a regularizer provides a strong theoretical and empirical foundation for handling outliers. While the multi-stage nature of L2S introduces some computational overhead, the gains in clinical reliability—especially for difficult diagnostic cases—are substantial. Future work may focus on optimizing inference latency for real-time clinical applications and further refining the adaptive thresholding mechanisms.
Summary updated